JPMorgan analyst John Royall lowered the firm’s price target on Delek US to $26 from $27 and keeps an Underweight rating on the shares. Despite fresh concerns around the demand side given fears of banking sector contagion seeping into the broader economy, refiners have held up relatively well given the circumstances, the analyst tells investors in a research note.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DK:
- Delek US announces senior leadership changes
- Delek US price target lowered to $25 from $30 at Mizuho
- Delek US initiated with a Neutral at UBS
- Delek US names Patrick Reilly Chief Commercial Officer
- Delek US Holdings Reports Fourth Quarter 2022 Results and Raises Quarterly Regular Dividend by $0.01 to $0.22 per share
